Skip to content
  • Home
  • IOncology
  • Infectious Desease Frontier
  • IHepatology
  • Hematology Frontier
  • Conference topics
  • Experts Interviews
  • Informations
  • Live Broadcasting
  • Logout
MediaMedic

Connecting Medical Expertise through Media

  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations
  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations

International Hepatology

Home » International Hepatology » Page 7
Deep Learning-Based Prognostication for Hepatocellular Carcinoma: A Multimodal Imaging Approach

Deep Learning-Based Prognostication for Hepatocellular Carcinoma: A Multimodal Imaging Approach

Posted by By Lisa Cui 2025.01.20
Introduction: Hepatocellular carcinoma (HCC) is a major global health burden, ranking as the third leading cause of cancer-related deaths worldwide. Despite liver resection being a curative option in the Asia-Pacific…
Read More
JAMA Network Open丨Dr. Fanpu Ji’s Team: Trends and Projections of Hepatocellular Carcinoma Mortality Rates in the U.S.

JAMA Network Open丨Dr. Fanpu Ji’s Team: Trends and Projections of Hepatocellular Carcinoma Mortality Rates in the U.S.

Posted by By Mourabit Halima 2025.01.20
Editor's Note: A recent study titled “Trends in Hepatocellular Carcinoma Mortality Rates in the US and Projections Through 2040” by Dr. Fanpu Ji’s team from the Second Affiliated Hospital of…
Read More
AASLD Exclusive Interview with Dr. Jiangao Fan: New Insights and Advances in Fatty Liver Disease

AASLD Exclusive Interview with Dr. Jiangao Fan: New Insights and Advances in Fatty Liver Disease

Posted by By Mourabit Halima 2025.01.13
During the recently concluded 75th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD), we had the privilege of conducting an in-depth interview with Dr. Jiangao…
Read More
AASLD China Spotlight丨Dr. Xin Zheng and Dr. Jia Liu’s Team Unveils Early Immunological Mechanisms in TMF Treatment for Chronic Hepatitis B

AASLD China Spotlight丨Dr. Xin Zheng and Dr. Jia Liu’s Team Unveils Early Immunological Mechanisms in TMF Treatment for Chronic Hepatitis B

Posted by By Peng Longmei 2025.01.07
Editor's Note: In the field of viral hepatitis, while most chronic hepatitis B (CHB) patients receiving tenofovir alafenamide (TMF) antiviral therapy experience a rapid decline in HBV DNA levels, only…
Read More
Expert Interview with Dr. Jiajie Liao: Optimizing Cost-Effective Strategies for Hepatitis B Treatment

Expert Interview with Dr. Jiajie Liao: Optimizing Cost-Effective Strategies for Hepatitis B Treatment

Posted by By Mourabit Halima 2025.01.06
Recently, the American Association for the Study of Liver Diseases (AASLD 2024) was held in San Diego, USA. The prestigious event brought together leading experts and scholars in the field…
Read More
Expert Interview with Dr. Jun Li: New Insights into Hepatitis B-Related ACLF Research

Expert Interview with Dr. Jun Li: New Insights into Hepatitis B-Related ACLF Research

Posted by By Lisa Cui 2025.01.02
Acute-on-Chronic Liver Failure (ACLF) is one of the most severe and life-threatening liver diseases in China and the Asia-Pacific region. This complex condition arises from multiple factors, with host genetic…
Read More
AASLD Exclusive Interview with Dr. Grace Lai-Hung Wong: Quantitative HBsAg – A New Perspective in Advancing Hepatitis B Management and Functional Cure

AASLD Exclusive Interview with Dr. Grace Lai-Hung Wong: Quantitative HBsAg – A New Perspective in Advancing Hepatitis B Management and Functional Cure

Posted by By Peng Longmei 2024.12.27
With significant progress in hepatitis B treatment, particularly in the pursuit of a functional cure, the quantification of hepatitis B surface antigen (HBsAg) has emerged as a critical factor in…
Read More
AASLD Exclusive Interview with Dr. Vincent Wai-Sun Wong: Challenges and Frontiers in Managing MASLD in Asia

AASLD Exclusive Interview with Dr. Vincent Wai-Sun Wong: Challenges and Frontiers in Managing MASLD in Asia

Posted by By Lisa Cui 2024.12.26
The prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD) continues to rise globally, driven by the increasing rates of obesity and metabolic syndrome. Epidemiological studies indicate that by 2019, the…
Read More
AASLD Expert Interview丨Dr. Lungen Lu Shares New Advances in MASLD Research

AASLD Expert Interview丨Dr. Lungen Lu Shares New Advances in MASLD Research

Posted by By Peng Longmei 2024.12.24
From November 15 to 19, 2024, the Annual Meeting of the American Association for the Study of Liver Diseases (AASLD 2024) was held in San Diego, USA. Hepatology Digest invited…
Read More
AASLD 2024 | Dr. Hong Tang’s Team Advances HBV, MASLD, Liver Fibrosis, HCC, and ACLF Research

AASLD 2024 | Dr. Hong Tang’s Team Advances HBV, MASLD, Liver Fibrosis, HCC, and ACLF Research

Posted by By Mourabit Halima 2024.12.24
Recently, the 75th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) was held in San Diego, USA. At the event, a team led by Dr.…
Read More

Posts pagination

Previous page 1 … 5 6 7 8 9 … 20 Next page
Recent Posts
  • Getting to the Bottom of the Debate 2.0 | Metastatic Renal Cell Carcinoma: Extrapolating Second-Line Evidence and Individualizing First-Line Dual Immunotherapy Versus Immunotherapy–TKI Combinations—A Debate Between Professors Xuewen Jiang and Hailiang Zhang
  • Getting to the Bottom of the Debate 2.0 | Oligoprogressive mCRPC: Debating Local Therapy and the Sequencing of PARP Inhibitors and ¹⁷⁷Lu-PSMA-617—A Debate Between Professors Jianming Guo and Qing Zou
  • Professor Dingwei Ye and Professor Xiaojie Bian: Breaking Through Treatment Challenges in mCRPC with Sacituzumab Tirumotecan Plus Immunotherapy for Durable Survival Benefits
  • 2026 CSCO | Professor Dingwei Ye and Professor Yao Zhu: Novel Breakthrough with a China-Developed TROP2 ADC—Sacituzumab Tirumotecan Demonstrates Significant Clinical Value in Advanced Urothelial Carcinoma
  • Professor Olive Daniel: From Basic Research to Clinical Treatment — Translational Pathways in Immune Regulation and Prospects for China-France Collaboration | 2026 China-France Scientific Symposium on Hematology and Immunology
Recent Comments
    Archives
    • October 2026
    • September 2026
    • August 2026
    • July 2026
    • June 2026
    • May 2026
    • April 2026
    • March 2026
    • February 2026
    • January 2026
    • December 2025
    • November 2025
    • October 2025
    • September 2025
    • August 2025
    • July 2025
    • June 2025
    • May 2025
    • April 2025
    • March 2025
    • February 2025
    • January 2025
    • December 2024
    • November 2024
    • October 2024
    • September 2024
    • August 2024
    • July 2024
    • June 2024
    • May 2024
    • April 2024
    • March 2024
    • February 2024
    • January 2024
    • December 2023
    • November 2023
    • October 2023
    • August 2023
    Categories
    • Artificial intelligence
    • Hematology Frontier
    • Infectious Disease Frontier
    • International Hepatology
    • IOncology
    • Live broadcasting
    • Uncategorized
    • UroStream
    • LinkedIn
    • Twitter
    • Mail
    Related Media:
    Copyright 2026 — MediaMedic. All rights reserved. Blogun WordPress Theme
    Paris, France
    Scroll to Top